Articles Archives - Page 203 of 715

WednesdayNov 23, 2022 9:45 am

HeartBeam Inc. (NASDAQ: BEAT) Announces New Chief Medical Officer

New Chief Medical Officer will play a major role in defining best paths to adoption, clinical strategies, and partnerships Dr. Fitzgerald serves as director of the Center for Cardiovascular Technology and of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School Dr. Fitzgerald brings impressive expertise in the clinical, research and industry sectors In a display of its commitment to offering innovative, high-quality products and services, cardiac tech company HeartBeam (NASDAQ: BEAT) has named a world-renowned interventional cardiologist with an impressive breadth of experience as its Chief Medical Officer (https://ibn.fm/pN1kf). Stanford cardiologist Peter J. Fitzgerald, MD, PhD, will help…

WednesdayNov 23, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Animal Study to Evaluate Potential Therapeutic Effect of DehydraTECH-CBD on Dementia

Lexaria Bioscience has launched DEM-A22-1, its first-ever study to investigate whether its patented DehydraTECH(TM)-processed CBD may have therapeutic use against dementia The animal study will involve a total of 32 Long Evans rats and will involve a memory assessment test that will be utilized to investigate whether CBD enables cognitive performance enhancements Previous independent studies have shown that CBD prevents the development of a social recognition deficit, a symptom frequently reported in Alzheimer’s disease patients, and is linked to memory impairment The laboratory work is expected to complete January 2023, with data and reporting to follow likely in April 2023…

TuesdayNov 22, 2022 2:15 pm

Lift Vancouver 2023 Dedicated To Uplifting The Cannabis Community In Canada

Lift Vancouver 2023 is to be held at the Vancouver Convention Center from January 12-14, 2023. Lift is a leading event-organizing company engaged in organizing high-quality cannabis events in North America, each of which is curated and designed for multiple audiences within the cannabis industry and community. The event is a grand forum for both established and new businesses, offering them the opportunity to gain visibility in the wider cannabis spectrum and the chance at discovery by investors, partners and media. Attended by cannabis industry stalwarts and fresh voices alike, this coveted event showcases the presence of cannabis businesses, growers,…

TuesdayNov 22, 2022 1:30 pm

Resourcing Tomorrow, by Mines and Money London, To Offer Key Insights Into Latest Energy Sustainability Issues

Mining leaders and professionals, policymakers, regulators, investors, and educators, are invited to the Resourcing Tomorrow - Mines and Money London conference, being held November 29 - December 1, 2022, at the Business Design Centre, London. The topics to be covered by experts are dedicated to global sustainability goals, including energy transition, ESG, decarbonization, and the circular economy. Mines and Money London is Europe’s leading conference that offers valuable insights into mining, energy and sustainability. witness 2000 attendees with 150+ businesses pitching their goals and ideas in front of 500+ potential investors. Be a part of the 120 talks, panel discussions…

TuesdayNov 22, 2022 12:45 pm

REZYFi, Inc. Continues to See Opportunity in Serving Cannabis-Related Companies Amid Marijuana Rescheduling Efforts in the US

REZYFi is a Miami, Florida-headquartered growth mortgage origination and specialized financing company that primarily targets licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies Traditional banks are governed by federal law, which criminalizes marijuana; as a result, they are hesitant to offer financial services to cannabis businesses The President recently set a process in motion that could culminate in the rescheduling of marijuana, although given that this review will not actually decriminalize the substance, the status quo, which disadvantages cannabis companies, will remain REZYFi believes cannabis-related companies will continue to experience difficulties accessing financing…

TuesdayNov 22, 2022 12:00 pm

SideChannel Inc. (SDCH) Is ‘One to Watch’

SideChannel recently released Enclave, its first software product The company acquired SideChannel in July 2022 and changed its name post-acquisition An industry benchmark study puts average CISO compensation at $463,000 annually, making SideChannel’s vCISO model attractive to its SMB target market According to IBM, the average cost to organizations of a cybersecurity breach is $4.2 million Cybersecurity Ventures reports a lack of trained professionals will leave 3.5 million cybersecurity positions unfilled by 2025, increasing demand for virtual security services SideChannel (OTCQB: SDCH) simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower…

TuesdayNov 22, 2022 11:15 am

Correlate Infrastructure Partners Inc. (CIPI) Eyeing Big Net Gains Following the Enactment of the Inflation Reduction Act; Has Finalized M&A Plans Through Q2 2023 and Posted Revenue Jump

With the recently passed Inflation Reduction Act, Correlate looks to achieve significant net gains The company just posted a significant revenue bump from $236,690 in Q2 2022 to $2,313,577 in Q3 2022, plus shows project opportunities of up to $194 million Todd Michaels, Correlate’s CEO, has also noted the company’s finalized M&A plans through Q2 2023, integral to scaling up the size and overall value of its projects and further growing revenue In September, the company entered into a non-binding letter of intent to acquire Vermont-based Aegis Renewable Energy Inc., which, once finalized, will present Correlate with new strategic abilities…

TuesdayNov 22, 2022 10:30 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Helping with the Switch to Cleaner Ammonia Generation in Light of the world’s 2050 Net Zero Goal

Ammonia is a highly efficient carrier of both hydrogen and nitrogen, with nitrogen being a critical component to fertilizers and world food production, but traditional ammonia production results in large greenhouse gas emissions FuelPositive’s carbon-free “green ammonia” production technology represents an environmentally superior way of producing ammonia The company’s confidence in its product has seen it go the extra mile to develop on-farm containerized, green ammonia production systems, that can be leveraged on a smaller scale to create green ammonia for agricultural fertilizers on-site FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a company focused on licensing, partnership, and acquisition opportunities related to…

TuesdayNov 22, 2022 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event

BiondVax summarizes collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen to discover and develop nanosized antibody (NanoAb) therapies that address underserved and growing markets, including COVID-19, psoriasis, asthma, psoriatic arthritis and wet macular degeneration. The global COVID-19 therapy market was valued at $16.8 billion in 2021 and is expected to grow at a CAGR of 20% during the forecast period, resulting in a value of $35.42 billion by 2025 The psoriasis market is experiencing a higher-than-expected demand across all regions due to the increasing geriatric population and the growing prevalence of plaque…

TuesdayNov 22, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Announces First European Dosing in Potentially Pivotal GBM Trial

The National Brain Tumor Society anticipates that more than 13,000 Americans will receive a GBM diagnosis during 2022, accounting for 49.1% of all primary malignant brain tumors CNS announced the first patient in Europe has been enrolled and dosed in the global trial to evaluate Berubicin for the treatment of GBM Berubicin is a novel anthracycline and the first to appear to cross the blood-brain barrier The global GBM treatment market is expected to reach a value of $4.2 billion by 2028, driven by the increased approval granted by the FDA for novel GBM treatment therapies CNS Pharmaceuticals (NASDAQ: CNSP),…

Site Search

Company Search

Category: Articles